Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1993-05-24
1995-01-03
Lacey, David L.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
4241421, 4241501, 43524027, 435 732, C07K 1528, A61K 39395, C12N 522, G01N 33554
Patent
active
053788125
ABSTRACT:
Cell lines have been produced that secrete human monclonal antibodies capable of binding to the lipopolysaccharide molecules of selected Pseudomonas aeruginosa IATS serotypes. Pharmaceutical compositions containing these antibodies, which can be in combination with other monoclonal antibodies, blood plasma fractions and antimicrobial agents, and the prophylactic and therapeutic use of such compositions in the management of infections are included.
Prior to filing of this patent application the continuous transformed human cell lines 1C1, 6D6, and 8H7 described herein were deposited in the American Type Culture Collection and given the designations CRL 8941, 9171, and. 9258, respectively.
REFERENCES:
patent: 4464465 (1984-08-01), Lostrom
patent: 4587121 (1986-05-01), Collins et al.
patent: 4677070 (1987-06-01), Larrick et al.
patent: 4734279 (1988-03-01), Stephan et al.
patent: 4777136 (1988-10-01), Young
Gross, A. S. et al., I&I, 61(7):2741-2747, Jul. 1993.
Verhoef, J. et al, Eur. J. Clin Microbiol. Infect Dis., 9(4):247-250, Apr. 1990.
Lang et al., Infect. Immun. 57:3851-3855 (1989).
Zweerink et al., Infect. Immun. 56:1873-1879 (1988).
Larrick et al., Human Hybridomas: Diagnostic and Therapeutic Applications A. J. Strelkaukas (ed.) (1987), pp. 65-80.
Pier et al., Infect. Immun. 45: 309-313 (1984).
Pier et al., J. Clin. Invest. 69: 303-308 (1982).
Hector et al., J. Infect. Dis. 160: 483-489 (1989).
Sawada, S. et al. "Protection Against Infection with Pseudomonas aeruginosa by Passive Transfer of Monoclonal Antibodies to Lipopolysaccharides and Outer Membrane Proteins," J. Infect. Dis. 150(4):570-576, 1984.
Liu, P. V. et al "Survey of Heat-Stable, Major Somatic Antigens of Pseudomonas aeruginosa," Int. Journal Systematic Bacteriology 33(2): 256-264, Apr. 1983.
Pollack, Immunoglobulins: Characteristics and Uses of Intravenous Preparations, Alving and Finlayson, eds., pp. 73-79, U.S. Department of Health and Human Services, 1979.
Pollack and Young, J. Clin. Invest. (1979) 63:276-279.
Cryz et al., Infect. Immun. (1983) 39:1072-1079.
Collins and Roby, Am. J. Med. (1984) pp. 168-174.
Zinner and McCabe, J. Infect. Dis. (1976) 133:37-45.
Clumeck et al., Bacterial Endotoxins and Host Response, M. K. Agarwal, ed., Elsevier/North-Holland Biomedical Press, pp. 79-93, 1980.
Teng et al., Proc. Natl. Acad. Sci. USA (1985) 82:1790-1794.
Hornberger et al., Fed. Am. Soc. Exp. Biol., 69th Annual Meeting, 1985, Abstracts of Papers, No. 5366.
Hancock et al., Infect. Immun. (1982) 37:166-171.
Mackie et al., J. Immunol. (1982) 129:829-832.
Darveau and Hancock, J. Bacteriol. (1983) 155:831-838.
Lam et al., Infect. Immun. (1983) 42:88-98.
Sadoff et al., Program and Abstracts of the Twenty-second Interscience Conference on Antimicrobial Agents and Chemotherapy, Oct. 1982, Abstract No. 253.
Siadak and Lostrom, Human Hybridomas and Monoclonal Antibodies, Engleman et al., eds., Plenum Publishing Corporation, 1985, pp. 167-185.
Sadoff et al., Antibiot. Chemother. (1985) 36:134-146.
Sawada et al., J. Infect. Dis. (1985) 152:965-970.
Koskimies, Scand. J. Immunol. (1980) 11:73-77.
Steinitz et al., J. Immunol. (1984) 132:877-882.
Yarchoan et al., J. Exper. Med. (1983) 157:1-14.
Larrick, U.S. Statutory Invention Reg. No. H494, Jul. 5, 1988.
Engleman, E. G. et al. Human Hybridomas and Monoclonal Antibodies, Plenum Press, New York, 1985, p. xi.
Lang, et al., "Immunoprotective Capacities of Human and Murine Monoclonal Antibodies Recognizing Serotype-Specific and Common Determinants of Gram-Negative Bacteria", in Therapeutic Monoclonal Antibodies ed. Borrebaeck & Larrick, pp. 223-234, 1990.
Rosok Mae J.
Siadak Anthony W.
Bristol--Myers Squibb Company
Lacey David L.
Loring Susan A.
LandOfFree
Monoclonal antibodies cross-reactive and cross-protective agains does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies cross-reactive and cross-protective agains, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies cross-reactive and cross-protective agains will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2212427